300 related articles for article (PubMed ID: 27446498)
21. The association of 18F-fluorodeoxyglucose PET/computed tomography parameters with tissue gastrin-releasing peptide receptor and integrin αvβ3 receptor levels in patients with breast cancer.
Arslan E; Aksoy T; Can Trabulus FD; Kelten Talu C; Yeni B; Çermik TF
Nucl Med Commun; 2020 Mar; 41(3):260-268. PubMed ID: 31895261
[TBL] [Abstract][Full Text] [Related]
22. Clinical Translation of a Dual Integrin αvβ3- and Gastrin-Releasing Peptide Receptor-Targeting PET Radiotracer, 68Ga-BBN-RGD.
Zhang J; Niu G; Lang L; Li F; Fan X; Yan X; Yao S; Yan W; Huo L; Chen L; Li Z; Zhu Z; Chen X
J Nucl Med; 2017 Feb; 58(2):228-234. PubMed ID: 27493267
[TBL] [Abstract][Full Text] [Related]
23. Targeted radiotherapy of prostate cancer with a gastrin-releasing peptide receptor antagonist is effective as monotherapy and in combination with rapamycin.
Dumont RA; Tamma M; Braun F; Borkowski S; Reubi JC; Maecke H; Weber WA; Mansi R
J Nucl Med; 2013 May; 54(5):762-9. PubMed ID: 23492884
[TBL] [Abstract][Full Text] [Related]
24. N-terminal modifications improve the receptor affinity and pharmacokinetics of radiolabeled peptidic gastrin-releasing peptide receptor antagonists: examples of 68Ga- and 64Cu-labeled peptides for PET imaging.
Gourni E; Mansi R; Jamous M; Waser B; Smerling C; Burian A; Buchegger F; Reubi JC; Maecke HR
J Nucl Med; 2014 Oct; 55(10):1719-25. PubMed ID: 25146125
[TBL] [Abstract][Full Text] [Related]
25. Correlation of
Duan H; Baratto L; Fan RE; Soerensen SJC; Liang T; Chung BI; Thong AEC; Gill H; Kunder C; Stoyanova T; Rusu M; Loening AM; Ghanouni P; Davidzon GA; Moradi F; Sonn GA; Iagaru A
J Nucl Med; 2022 Dec; 63(12):1829-1835. PubMed ID: 35552245
[No Abstract] [Full Text] [Related]
26. First-in-human dosimetry of gastrin-releasing peptide receptor antagonist [
Kurth J; Krause BJ; Schwarzenböck SM; Bergner C; Hakenberg OW; Heuschkel M
Eur J Nucl Med Mol Imaging; 2020 Jan; 47(1):123-135. PubMed ID: 31482426
[TBL] [Abstract][Full Text] [Related]
27. PET Imaging Using Gallium-68 (
Duan H; Iagaru A
PET Clin; 2022 Oct; 17(4):621-629. PubMed ID: 36153233
[TBL] [Abstract][Full Text] [Related]
28. Expression of Gastrin-Releasing Peptide Receptor in Breast Cancer and Its Association with Pathologic, Biologic, and Clinical Parameters: A Study of 1,432 Primary Tumors.
Morgat C; MacGrogan G; Brouste V; Vélasco V; Sévenet N; Bonnefoi H; Fernandez P; Debled M; Hindié E
J Nucl Med; 2017 Sep; 58(9):1401-1407. PubMed ID: 28280221
[TBL] [Abstract][Full Text] [Related]
29. GRPr Antagonist
Bakker IL; Fröberg AC; Busstra MB; Verzijlbergen JF; Konijnenberg M; van Leenders GJLH; Schoots IG; de Blois E; van Weerden WM; Dalm SU; Maina T; Nock BA; de Jong M
J Nucl Med; 2021 Nov; 62(11):1517-1523. PubMed ID: 33789933
[TBL] [Abstract][Full Text] [Related]
30. Theranostic Perspectives in Prostate Cancer with the Gastrin-Releasing Peptide Receptor Antagonist NeoBOMB1: Preclinical and First Clinical Results.
Nock BA; Kaloudi A; Lymperis E; Giarika A; Kulkarni HR; Klette I; Singh A; Krenning EP; de Jong M; Maina T; Baum RP
J Nucl Med; 2017 Jan; 58(1):75-80. PubMed ID: 27493272
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, preclinical, and initial clinical evaluation of integrin α
Wen X; Wang R; Xu P; Shi M; Shang Q; Zeng X; Zeng X; Liu J; Wang X; Zhu Z; Guo Z; Chen X; Zhang J
Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):2023-2035. PubMed ID: 38376806
[TBL] [Abstract][Full Text] [Related]
32. Bombesin antagonist-based radioligands for translational nuclear imaging of gastrin-releasing peptide receptor-positive tumors.
Abiraj K; Mansi R; Tamma ML; Fani M; Forrer F; Nicolas G; Cescato R; Reubi JC; Maecke HR
J Nucl Med; 2011 Dec; 52(12):1970-8. PubMed ID: 22080443
[TBL] [Abstract][Full Text] [Related]
33. Modified PROMISE criteria for standardized interpretation of gastrin-releasing peptide receptor (GRPR)-targeted PET.
Duan H; Davidzon GA; Moradi F; Liang T; Song H; Iagaru A
Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):4087-4095. PubMed ID: 37555901
[TBL] [Abstract][Full Text] [Related]
34. PET of tumors expressing gastrin-releasing peptide receptor with an 18F-labeled bombesin analog.
Dijkgraaf I; Franssen GM; McBride WJ; D'Souza CA; Laverman P; Smith CJ; Goldenberg DM; Oyen WJ; Boerman OC
J Nucl Med; 2012 Jun; 53(6):947-52. PubMed ID: 22570329
[TBL] [Abstract][Full Text] [Related]
35. Voxel-based comparison of [
Fassbender TF; Schiller F; Zamboglou C; Drendel V; Kiefer S; Jilg CA; Grosu AL; Mix M
EJNMMI Res; 2020 Jun; 10(1):62. PubMed ID: 32533273
[TBL] [Abstract][Full Text] [Related]
36. A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging.
Pan D; Xu YP; Yang RH; Wang L; Chen F; Luo S; Yang M; Yan Y
Amino Acids; 2014 Jun; 46(6):1481-9. PubMed ID: 24633452
[TBL] [Abstract][Full Text] [Related]
37. 68Ga-RM2 PET in PSMA- positive and -negative prostate cancer patients.
Hoberück S; Michler E; Wunderlich G; Löck S; Hölscher T; Froehner M; Braune A; Ivan P; Seppelt D; Zöphel K; Kotzerke J
Nuklearmedizin; 2019 Sep; 58(5):352-362. PubMed ID: 31443113
[TBL] [Abstract][Full Text] [Related]
38. Imaging GRPr Expression in Metastatic Castration-Resistant Prostate Cancer with [
Fernández R; Soza-Ried C; Iagaru A; Stephens A; Müller A; Schieferstein H; Sandoval C; Amaral H; Kramer V
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201600
[TBL] [Abstract][Full Text] [Related]
39.
Wang L; Bratanovic IJ; Zhang Z; Kuo HT; Merkens H; Zeisler J; Zhang C; Tan R; Bénard F; Lin KS
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838968
[TBL] [Abstract][Full Text] [Related]
40. 68Ga-NOTA-Aca-BBN(7-14) PET/CT in Healthy Volunteers and Glioma Patients.
Zhang J; Li D; Lang L; Zhu Z; Wang L; Wu P; Niu G; Li F; Chen X
J Nucl Med; 2016 Jan; 57(1):9-14. PubMed ID: 26449838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
